knowledge -WSS

knowledge

author：focus 2025-09-28 23:29:40 - browse：923

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： IRA could hurt research into orphan drugs for rare diseases

WSS

Hospitals consider fixing cancer drug shortages on their own

Medicare innovation center doesn’t save money, experts say

The United States is paying nearly triple for new Covid vaccines

Pig kidney works a record two months in donated body

How medical schools plan to diversify without affirmative action

Lawsuit highlights wrinkle for disputes over surprise medical bills

focus

knowledge

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Food makers to regulators: Ultra

Wildfire smoke exposes gaps in outdoor worker protections

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Psychedelics group wrestles with new pharma identity

Acelyrin, a rare IPO success, stumbles in its first big test

Moonlake's readout produced a cash windfall. Risks remain

New Covid vaccine is recommended for everyone 6 months or older

Guidelines to prevent youth baseball injuries need more muscle

New Covid vaccine is recommended for everyone 6 months or older

focus

IRA could hurt research into orphan drugs for rare diseases

6 solutions to address cancer drug shortages and others

Setback for rare diseases as Taysha Gene Therapies pulls back

New oral drug delivery patch is modeled after octopus tentacles

Setback for rare diseases as Taysha Gene Therapies pulls back

New weight loss drugs vying to be the next Wegovy or Mounjaro

leisure time

explore

leisure time

Wikipedia